Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
22.2M
-
Shares change
-
+1.53M
-
Total reported value, excl. options
-
$288M
-
Value change
-
+$16.3M
-
Number of buys
-
49
-
Number of sells
-
-27
-
Price
-
$13.02
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q2 2015
94 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q2 2015.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.2M shares
of 49.8M outstanding shares and own 44.51% of the company stock.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (6.42M shares), BlackRock Fund Advisors (1.71M shares), VANGUARD GROUP INC (1.6M shares), FIRST MANHATTAN CO (1.17M shares), OPPENHEIMER FUNDS INC (1.1M shares), NORGES BANK (1M shares), ARMISTICE CAPITAL, LLC (974K shares), STATE STREET CORP (863K shares), BlackRock Institutional Trust Company, N.A. (725K shares), and Foundation Asset Management, LP (584K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.